Latest news with #HELM
Arabian Business
09-05-2025
- Business
- Arabian Business
Abu Dhabi Investment Office expands San Francisco operation as it targets $25.3tn healthcare market
The Abu Dhabi Investment Office (ADIO) has announced plans to expand operations of its office in San Francisco to support the global expansion of Abu Dhabi's economic clusters. At an epicentre of health tech, biotech, and venture capital, the expansion of the San Francisco office will promote Abu Dhabi's fast-track clinical validation and regulatory pathways to serve as a launchpad for global innovation in healthcare, as well as other priority sectors. The Abu Dhabi's Health, Endurance, Longevity and Medicine cluster (HELM), launched in April 2025 by the Abu Dhabi Department of Economic Development (ADDED) and Abu Dhabi Investment Office (ADIO) in partnership with the Department of Health – Abu Dhabi, is projected to contribute $25.6bn to Abu Dhabi's GDP, unlock 30,000 new jobs, and attract $11.5bn in investment by 2045. Abu Dhabi Investment Office The Cluster, tapping growth opportunities in the global healthcare market, which is projected to reach $25.3tn by 2045, will be a key area of focus for the San Francisco office. One of the largest global health innovation initiatives of its kind, HELM leverages Abu Dhabi's strengths in genomics, population health intelligence, AI in healthcare and regulatory agility. ADIO office will enable US-based startups and scale-ups to join other leading US healthcare firms, such as Insilico Medicine and Innovaccer, in expanding to Abu Dhabi. The announcement was made as part of a high-level delegation visit to San Francisco, led by Mansoor Ibrahim Al Mansoori, Chairman of the Department of Health – Abu Dhabi, to strengthen strategic partnerships and hold meetings with decision-makers, entrepreneurs, and representatives of leading institutions in the health technology and innovation sector in the region. Ahmed Jasim Al Zaabi, Chairman of the Abu Dhabi Department of Economic Development (ADDED), said: 'ADIO's office in San Francisco is more than a presence, it's a platform for investment matching, market entry, and long-term growth. 'By expanding our operations in San Francisco, we're not only opening new doors to Abu Dhabi's business ecosystem, we're building two-way bridges for capital, innovation, and impact across multiple innovation-driven sectors.' Mansoor Ibrahim Al Mansoori, Chairman of the Department of Health – Abu Dhabi, said: 'The future of health cannot be built in isolation; it must be co-created. The expansion of ADIO's office in San Francisco will give health innovators, and entrepreneurs the opportunity to build, test, and scale solutions with Abu Dhabi, for the world. 'As a Living Lab for real-world health innovation, backed by agile, innovation focused regulations, capital and infrastructure, we offer a platform where global ideas can scale and create impact.' Announced during Abu Dhabi Global Health Week 2025, the HELM cluster serves as a launchpad for health and life sciences companies seeking to tap into strategic capital with partners in Abu Dhabi, fast-track market validation through Abu Dhabi's digitally integrated clinical trial and regulatory infrastructure, simultaneously access and expand across two high-value markets—the US and the Middle East, collaborate with leading UAE-based research institutions and healthcare providers and scale globally with bespoke advisory and partnership support.
Zawya
09-05-2025
- Business
- Zawya
Abu Dhabi Investment Office to expand San Francisco office to attract further US investment
ABU DHABI - The Abu Dhabi Investment Office (ADIO) has announced plans to expand operations of its office in San Francisco to support the global expansion of Abu Dhabi's economic clusters. At an epicentre of health tech, biotech, and venture capital, the expansion of the San Francisco office will promote Abu Dhabi's fast-track clinical validation and regulatory pathways to serve as a launchpad for global innovation in healthcare, as well as other priority sectors. The Abu Dhabi's Health, Endurance, Longevity and Medicine cluster (HELM), launched in April 2025 by the Abu Dhabi Department of Economic Development (ADDED) and Abu Dhabi Investment Office (ADIO) in partnership with the Department of Health – Abu Dhabi, is projected to contribute US$25.6 billion to Abu Dhabi's GDP, unlock 30,000 new jobs, and attract US$11.5 billion in investment by 2045. The Cluster, tapping growth opportunities in the global healthcare market, which is projected to reach US$25.3 trillion by 2045, will be a key area of focus for the San Francisco office. One of the largest global health innovation initiatives of its kind, HELM leverages Abu Dhabi's strengths in genomics, population health intelligence, AI in healthcare and regulatory agility. ADIO office will enable US-based startups and scale-ups to join other leading US healthcare firms, such as Insilico Medicine and Innovaccer, in expanding to Abu Dhabi. The announcement was made as part of a high-level delegation visit to San Francisco, led by Mansoor Ibrahim Al Mansoori, Chairman of the Department of Health – Abu Dhabi, to strengthen strategic partnerships and hold meetings with decision-makers, entrepreneurs, and representatives of leading institutions in the health technology and innovation sector in the region. Ahmed Jasim Al Zaabi, Chairman of the Abu Dhabi Department of Economic Development (ADDED), said, 'ADIO's office in San Francisco is more than a presence, it's a platform for investment matching, market entry, and long-term growth. By expanding our operations in San Francisco, we're not only opening new doors to Abu Dhabi's business ecosystem, we're building two-way bridges for capital, innovation, and impact across multiple innovation-driven sectors.' Mansoor Ibrahim Al Mansoori, Chairman of the Department of Health – Abu Dhabi, said, 'The future of health cannot be built in isolation; it must be co-created. The expansion of ADIO's office in San Francisco will give health innovators, and entrepreneurs the opportunity to build, test, and scale solutions with Abu Dhabi, for the world. As a Living Lab for real-world health innovation, backed by agile, innovation focused regulations, capital and infrastructure, we offer a platform where global ideas can scale and create impact.' Announced during Abu Dhabi Global Health Week 2025, the HELM cluster serves as a launchpad for health and life sciences companies seeking to tap into strategic capital with partners in Abu Dhabi, fast-track market validation through Abu Dhabi's digitally integrated clinical trial and regulatory infrastructure, simultaneously access and expand across two high-value markets—the US and the Middle East, collaborate with leading UAE-based research institutions and healthcare providers and scale globally with bespoke advisory and partnership support.
Al Etihad
08-05-2025
- Business
- Al Etihad
Abu Dhabi Investment Office to expand San Francisco office to attract further US investment into the emirate's health sector
8 May 2025 16:39 ABU DHABI (ALETIHAD)The Abu Dhabi Investment Office (ADIO) has announced plans to expand the operations of its office in San Francisco to support the global expansion of Abu Dhabi's economic clusters. At an epicentre of health tech, biotech, and venture capital, the expansion of the San Francisco office will promote Abu Dhabi's fast-track clinical validation and regulatory pathways to serve as a launchpad for global innovation in healthcare, as well as other priority Abu Dhabi's Health, Endurance, Longevity, and Medicine cluster (HELM), launched in April 2025 by the Abu Dhabi Department of Economic Development (ADDED) and Abu Dhabi Investment Office (ADIO) in partnership with the Department of Health – Abu Dhabi, is projected to contribute $25.6 billion to Abu Dhabi's GDP, unlock 30,000 new jobs, and attract $11.5 billion in investment by Cluster, tapping growth opportunities in the global healthcare market, which is projected to reach $25.3 trillion by 2045, will be a key area of focus for the San Francisco office. One of the largest global health innovation initiatives of its kind, HELM leverages Abu Dhabi's strengths in genomics, population health intelligence, AI in healthcare, and regulatory agility. ADIO office will enable US-based startups and scaleups to join other leading US healthcare firms, such as Insilico Medicine and Innovaccer, in expanding to Abu announcement was made as part of a high-level delegation visit to San Francisco, led by the Chairman of the Department of Health – Abu Dhabi, His Excellency Mansoor Ibrahim Al Mansoori, to strengthen strategic partnerships and hold meetings with decision-makers, entrepreneurs, and representatives of leading institutions in the health technology and innovation sector in the of the Abu Dhabi Department of Economic Development (ADDED), His Excellency Ahmed Jasim Al Zaabi, said, 'ADIO's office in San Francisco is more than a presence, it's a platform for investment matching, market entry, and long-term growth. By expanding our operations in San Francisco, we're not only opening new doors to Abu Dhabi's business ecosystem, we're building two-way bridges for capital, innovation, and impact across multiple innovation-driven sectors.'His Excellency Al Mansoori said, 'The future of health cannot be built in isolation; it must be co-created. The expansion of ADIO's office in San Francisco will give health innovators, and entrepreneurs the opportunity to build, test, and scale solutions with Abu Dhabi, for the world. As a Living Lab for real-world health innovation, backed by agile, innovation-focused regulations, capital and infrastructure, we offer a platform where global ideas can scale and create impact.' Announced during Abu Dhabi Global Health Week 2025, the HELM cluster serves as a launchpad for health and life sciences companies seeking to tap into strategic capital with partners in Abu Dhabi, fast-track market validation through Abu Dhabi's digitally integrated clinical trial and regulatory infrastructure, simultaneously access and expand across two high-value markets—the US and the Middle East, collaborate with leading UAE-based research institutions and healthcare providers and scale globally with bespoke advisory and partnership support.
Al Etihad
22-04-2025
- Health
- Al Etihad
Abu Dhabi's HELM cluster a big leap towards AI-driven healthcare
23 Apr 2025 00:27 MAYS IBRAHIM (ABU DHABI) Abu Dhabi is putting AI to work to help people live longer and healthier lives through software-driven diagnostics, predictive disease progression modelling, and tailored treatments. At the helm of this transformation is the newly launched Health, Endurance, Longevity, and Medicine (HELM) Cluster, led by the Abu Dhabi Department of Economic Development, Abu Dhabi Investment Office, and the Department of Health – Abu sat down with a key figure behind the initiative to explore what HELM truly means for the future of healthcare in Abu Dhabi and beyond. This exclusive interview with Dr. Fatma Al Mulla, Head of HELM Cluster, goes beyond the headlines to uncover the strategy, infrastructure, and motivations driving Abu Dhabi's investment in life sciences.'Through the Digital Health and AI Hub, we are supporting companies working on everything from SaMD (software as a medical device) and digital therapeutics to remote diagnostics. These are real applications with measurable outcomes, and we are backing them with the right combination of regulation, capital, and clinical access,' Dr. Al Mulla cluster is also exploring ways to leverage AI in order to make clinical trials more efficient and help hospitals run more smoothly.'It's not just about new tech, it's about making healthcare more responsive, personalised and sustainable,' said Dr. Al Mulla.'Backed by strong regulatory frameworks and access to AI-ready genomic and health datasets, Abu Dhabi provides a unique testbed for deploying scalable digital health solutions," she the Department of Health was the first in the MENA region to launch an AI policy for healthcare – a critical signal for companies seeking regulatory clarity, she said.'Through HELM, Abu Dhabi has the potential to become the go-to hub in the Middle East for healthy longevity, chronic disease management and innovative preventive care, not just because of our infrastructure, but because of our mindset. We move fast, we collaborate well, and we think long-term,' Dr. Al Mulla ImpactDr. Al Mulla noted that the cluster marks a pivotal step towards building a future-ready economy – one rooted in knowledge, innovation, and long-term resilience.'The HELM Cluster exemplifies how ADIO is spearheading economic transformation through targeted cluster development. We've been working toward strengthening our knowledge economy, driving innovation and creating sustainable, export-driven industries,' she said.'HELM is a big step forward for us…In many ways, it combines everything Abu Dhabi has been investing in over the past decade: world-class infrastructure, policy flexibility, and a deep belief in the power of science to solve real problems.'Within five years, HELM aims to establish a global reputation for driving innovation and delivering real-world impact.'This cluster is part of a broader shift. It moves Abu Dhabi to being a source of solutions, where treatments are developed, tested, and commercialised, all within a single ecosystem,' Dr. Al Mulla ImpactBy 2045, HELM is expected to contribute Dh94 billion to Abu Dhabi's GDP, attract Dh42 billion in investment, and generate over 30,000 high-value jobs. But, according to Dr. Al Mulla, the true value lies beyond the numbers.'We are building a self-sustaining innovation ecosystem that will accelerate drug discovery, strengthen clinical trials, and bring digital and personalised health solutions to market faster,' she goal is to support not just local health outcomes but also global healthcare systems, which are under growing pressure from chronic disease and ageing populations, she added.'Success for us is measured not just in economic impact, but in the acceleration of new diagnostics, therapies, and health technologies.'End-to-End Infrastructure for InnovationDr. Al Mulla noted that HELM has been designed to integrate every element needed to take healthcare innovation from the lab to the includes a bioscience park, advanced manufacturing centres, and clinical trial platforms, along with specialised research facilities for diagnostics, pharmaceuticals, and genomics.'Together, they create an end-to-end platform from discovery to delivery, underpinned by a strong regulatory and clinical trials infrastructure,' she also helps remove barriers that slow the lifecycle of medical innovation by connecting researchers, technologists, regulators and investors side by side.'That means shorter development cycles, smarter diagnostics and better patient outcomes,' Dr. Al Mulla cluster benefits from strong partnerships with entities such as Hub71 and the Department of Health Abu Dhabi, along with top-tier academic institutions like MBZUAI, NYU Abu Dhabi and Khalifa University.'That web of connections will keep innovation flowing, enabling next-gen drug discovery and development at scale,' Dr. Al Mulla the scenes, support services such as streamlined regulatory review, IP protection, access to datasets, and strategic investment mechanisms further differentiate HELM from other of the cluster's most powerful assets is the Genomics Oasis built on initiatives like the Emirati Genome Programme and data-sharing platforms such as Malaffi. With approximately over 650,000 samples already collected, Dr. Al Mulla pointed out that Abu Dhabi now offers one of the most diverse and comprehensive genomic datasets in the world, enabling breakthroughs in precision medicine, predictive diagnostics, and AI model Top TalentAccording to Dr. Al Mulla, HELM is investing heavily in education, training and mentorship to cultivate the next generation of life science leaders.'We're partnering with leading academic institutions, like NYU Abu Dhabi and UAE University, to ensure we're not just attracting global talent, but developing homegrown experts who understand the region's needs through tailored internships, training programmes, and research fellowships.'For international researchers and healthcare companies, Abu Dhabi offers a compelling package: fast-track clinical trial approvals, strong IP protections, global connectivity, and access to a market of 1.5 billion people within four hours. 'What we're building at HELM is more than a cluster; it's an ecosystem. And we want the best minds in the world to see it as a place where they can make a real difference,' Dr. Al Mulla
Zawya
18-04-2025
- Business
- Zawya
ADIO, DoH, Hub71 join forces to position Abu Dhabi as global epicentre for life sciences investment
Abu Dhabi: The Abu Dhabi Investment Office (ADIO) and the Department of Health – Abu Dhabi (DoH), the regulator of the health sector in the emirate of Abu Dhabi, today announced the signing of a strategic partnership with Hub71, Abu Dhabi's global tech ecosystem, to attract global venture capital (VC) investment and accelerate the growth of HealthTech and life sciences startups through the emirate's newly launched Health, Endurance, Longevity, and Medicine (HELM) cluster. Led by the Abu Dhabi Department of Economic Development (ADDED), ADIO and DoH, the HELM cluster was established to be a global hub for biotechnology, MedTech and digital health innovation. The cluster is projected to contribute AED 94 billion to Abu Dhabi's GDP and create 30,000 new jobs by 2045. Under the agreement, which was announced on the sidelines of Abu Dhabi Global Health Week (ADGHW), Hub71 will leverage its extensive VC partner network to showcase investment opportunities within the HELM clusterthrough targeted roadshows, networking engagements and dedicated promotional initiatives. ADIO will complement these efforts by providing attractive co-investment opportunities, tailored business support and streamlined business facilitation services to attract international VC firms to establish and expand their operations within the cluster. Hub71 will also proactively connect high-potential startups entering the HELM cluster with relevant VCs, allowing startups to benefit from targeted market access. DoH will provide compliance support while optimising regulatory pathways to attract and streamline investment processes in the life sciences sector. All parties will collaborate on policy and infrastructure enhancements, aligning Abu Dhabi's life sciences ecosystem with international best practices. Regular policy reviews will ensure continuous improvement, enhancing the investor experience and reinforcing Abu Dhabi's position as a top destination for life sciences investments. Dr. Noura Al Ghaithi, Under-Secretary of the Department of Health – Abu Dhabi, commented, 'For global investors and health innovators, Abu Dhabi offers more than a destination, it offers a launchpad. Through the HELM cluster, we are removing barriers, accelerating access, and providing the regulatory clarity and support that startups and investors need to scale faster and smarter. This partnership ensures that breakthrough reach the patients, markets, and communities that need them most. Badr Al Olama, Director-General of ADIO, said, 'This collaboration exemplifies Abu Dhabi's ability to accelerate high-growth sectors by creating the right environment for early-stage innovation to thrive. By partnering with the Department of Health – Abu Dhabi and Hub71, we are ensuring that promising ideas are matched with the capital, infrastructure and regulatory clarity they need to scale. This not only reinforces Abu Dhabi's position as a leading destination for life sciences investment, it also supports the HELM cluster's mission to deliver transformative advancements in healthcare and lasting economic impact across the emirate.' Ahmad Ali Alwan, CEO of Hub71, said, 'This partnership is a compelling example of how Abu Dhabi's ecosystem is mobilising to strengthen the HELM cluster. By connecting ventures with leading capital partners and a vibrant community of innovative startups, we are enabling breakthrough solutions and contributing to the future of global healthcare and life sciences.' As the MENA region's fastest growing startup ecosystem, Abu Dhabi witnessed US$4.2 billion in exit and startup valuations by the end of 2023. The emirate saw US$224 million in early-stage startup funding and over overall US$1 billion in VC funding between July 2021 and December 2023. Since 2021, DoH has supported 80 healthcare startups, accelerating transformative solutions across the healthcare spectrum. These efforts have created 926 specialised jobs, fostering economic growth and strengthening the life sciences sector, which has achieved an impressive annual growth rate of 22 percent. Held under the theme 'Towards Longevity: Redefining Health and Well-being', Abu Dhabi Global Health Week is a major government initiative from Department of Health – Abu Dhabi (DoH) to serve as a platform for innovation and collaboration within Abu Dhabi's healthcare sector.
